Studies presented at ENDO 2017 examined the impact of sleep disorders on gestational diabetes, bone formation, and adolescents with and without diabetes.
Samantha J. Peterson
You won’t want to miss these top sessions and new features at this year’s Endocrinology Society’s annual meeting, April 1-4, in Orlando, FL.
Our March list includes Testosterone Trials results, self-management in patients transitioning to adult care, and cancer mortality risk with diabetes.
Our February list includes a newly approved drug combo, the ADA’s position statement on diabetic retinopathy, and lifestyle intervention studies.
Our February list includes updated guidelines for pediatric obesity, American Heart Assoc. statement on meal timing & frequency, and diabetes risks.
Our January list includes new care guidelines for neuropathy, updates to oral medication recommendations, and long-term RYGB outcomes for adolescents.
Our December list includes pharmaceutical company responses to soaring insulin costs, delayed PCOS diagnosis, and dementia risk with ADT.
Our December list includes new care guidelines from the ADA, a new indication for an SGLT2i, and effects of PCI on CV, DM risk.
Does the obesity paradox exist in heart failure? What roles do ejection fraction and type 2 diabetes & acute decompensated heart failure play?
Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.